Mice with an intestine-specific <i>Acsl5</i> knockout are protected from high-fat diet (HFD)-induced obesity, insulin resistance, glucose intolerance and hepatic steatosis, and show increased GLP-1 levels, delayed gastric emptying (GE), and decreased food consumption (FC). Here, ACSL5 is linked to obesity disorder.